Efficacy of finasteride is maintained in patients with benign prostatic hyperplasia treated for 5 years - how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?

By Hudson P.B.   Boake R.   Trachtenberg J.   Romas N.A.   Rosenblatt S.   Narayan P.   Geller J.   Lieber M.M.   Elhilali M.   Norman R.   Patterson L.   Perreault J.-P.   Malek G.H.   Bruskewitz R.C.   Roy J.B.   Ko A.   Jacobsen C.A.   Stoner E.  

Urology, Vol. 53, Iss. 4, 1999-04 ,pp. : 690-695

Elsevier

Access to resources Recommend Favorite

Microwave Thermotherapy for Benign Prostatic Hyperplasia with the Dornier Urowave: Results of a Randomized, Double-blind, Multicenter, Sham-controlled Trial - how much change in AUA symptom index and the BPH impact index is perceptible to patients?

By Roehrborn C.G.   Preminger G.   Newhall P.   Denstedt J.   Razvi H.   Chin L.J.   Perlmutter A.   Barzell W.   Whitmore W.   Fritzsch R.   Sanders J.   Sech S.   Womack S.  

Urology, Vol. 51, Iss. 1, 1998-01 ,pp. : 19-28

Elsevier

Access to resources Recommend Favorite

Nocturia and benign prostatic hyperplasia

By Yoshimura K.   Ohara H.   Ichioka K.   Terada N.   Matsui Y.   Terai A.   Arai Y.  

Urology, Vol. 61, Iss. 4, 2003-04 ,pp. : 786-790

Elsevier

Access to resources Recommend Favorite

Prostaject ethanol injection therapy for benign prostatic hyperplasia- 12 month results

By Palmer J.   Subramonian K.   Keen M.  

European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. : 131-131

Elsevier

Access to resources Recommend Favorite

Current treatment options for benign prostatic hyperplasia and their impact on sexual function

By Larson T.R.  

Urology, Vol. 61, Iss. 4, 2003-04 ,pp. : 692-698

Elsevier

Access to resources Recommend Favorite